557
Views
3
CrossRef citations to date
0
Altmetric
Author's View

Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemia

, , &
Article: e941737 | Received 30 May 2014, Accepted 03 Jun 2014, Published online: 31 Oct 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Malte Roerden, Melanie Märklin, Helmut R. Salih, Wolfgang A. Bethge, Reinhild Klein, Hans-Georg Rammensee, Annika Nelde & Juliane S. Walz. (2021) Expression levels of HLA-DR in acute myeloid leukemia: implications for antigenicity and clinical outcome. Leukemia & Lymphoma 62:8, pages 1907-1919.
Read now

Articles from other publishers (2)

Ion Antohe, Mariana Pavel Tanasa, Angela Dăscălescu, Cătălin Dănăilă, Amalia Titieanu, Mihaela Zlei, Iuliu Ivanov, Adriana Sireteanu & Petru Cianga. (2021) The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns correlated with acute myeloid leukaemias blast cells HLA-DR expression. Immunobiology 226:1, pages 152049.
Crossref
Jacques Thibodeau, Mohamed Abdelwafi Moulefera & Renaud Balthazard. (2019) On the structure–function of MHC class II molecules and how single amino acid polymorphisms could alter intracellular trafficking. Human Immunology 80:1, pages 15-31.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.